Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
48.56
+1.48 (3.14%)
Jun 9, 2026, 4:00 PM EDT - Market closed
Travere Therapeutics Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Travere Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $55.07. The average 1-year stock price forecast is 13.41% higher than the current stock price, while the lowest is $43 (-11.45%) and the highest is $67 (+37.97%).
Price Target: $55.07 (+13.41%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Travere Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 12 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $67 | Buy | Reiterates | $67 | +37.97% | Jun 5, 2026 |
| Citi | Citi | Buy Reiterates $59 → $62 | Buy | Reiterates | $59 → $62 | +27.68% | Jun 3, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $56 | Buy | Maintains | $56 | +15.32% | Jun 3, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $49 | Buy | Maintains | $49 | +0.91% | Jun 3, 2026 |
| Wedbush | Wedbush | Buy Maintains $55 | Buy | Maintains | $55 | +13.26% | Jun 3, 2026 |
Financial Forecast
Revenue This Year
699.54M
from 490.73M
Increased by 42.55%
Revenue Next Year
969.50M
from 699.54M
Increased by 38.59%
EPS This Year
1.63
from 0.91
Increased by 79.34%
EPS Next Year
4.93
from 1.63
Increased by 201.95%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 941.1M | ||
| Avg | 699.5M | ||
| Low | 595.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 91.8% | ||
| Avg | 42.6% | ||
| Low | 21.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.80 | ||
| Avg | 1.63 | ||
| Low | 0.22 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 207.7% | ||
| Avg | 79.3% | ||
| Low | -76.2% |